Studies have found that recombinant PRV YP2 strain can selectively replicate and lyse HER-2/neu-overexpressing human bladder, mouse bladder, and hamster oral cancer cells in vitro [13]. The gene discussed is ERBB2; the disease is lip and oral cavity carcinoma.